Here’s Why Aligos Therapeutics, Inc. (ALGS) Is Skyrocketing

We recently compiled a list of the Why These 24 Stocks Are Skyrocketing. In this article, we are going to take a look at where Aligos Therapeutics, Inc. (NASDAQ:ALGS) stands against the other stocks.

One of the strongest stock market anomalies is the momentum effect, which is the tendency of recent past winners to outperform the recent past losers. That’s why we decided to take a look at some of the recent past winners in this article. These 24 companies, predominantly involved in the quantum computing, biotechnology, and technology sectors, have performed significantly well in the final quarter of 2024, registering spectacular returns over the 3 months.

That said, let’s take a look at the top 24 stocks that have skyrocketed and pose a solid growth opportunity in the coming year. We will also explore how well the stocks have performed throughout the year and what they have in store for 2025.

To come up with 24 names, we considered only the stocks that have at least $2 billion in market capitalization and have registered commendable returns in the fourth quarter of 2024.

A scientist standing in a lab examining a biopharmaceutical sample through a microscope.

Aligos Therapeutics, Inc. (NASDAQ:ALGS)

Q4 Returns as of December 31, 2024: 360%

ALGS registered a 360% increase in its stock price during the fourth quarter of 2024, going from $8.66 on September 30 to $39.84 apiece on December 31, 2024.

The surge in ALGS’ stock price underscores investor optimism and a positive investor outlook. Its growing popularity can be attributed to its expanding product pipeline and positive data from clinical trials.

Aligos Therapeutics (NASDAQ:ALGS) boasts an estimated opportunity worth $6.2 billion by 2031 as the number of patients with chronic hepatitis eyes an upward trajectory. So far, its trials have yielded positive results, boosting the company’s current and future position.

Overall ALGS ranks 7th on our list of the stocks that are skyrocketing right now. While we acknowledge the potential of ALGS as an investment, our conviction lies in the belief that certain AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ALGS but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure: None. This article is originally published at Insider Monkey.